The Effect of Epinephrine Spray on Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

Document Type : Original Article (s)

10.22122/jims.v39i621.13181

Abstract

Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is one of the life-threatening complications of ERCP. Numerous efforts have been made to decrease the risk of PEP; however, the results were controversial. The current study aimed to assess the efficacy of local epinephrine spray on PEP reduction.
Methods: 124 patients undergone ERCP were randomly divided into two groups of intervention (n = 67) and control (n = 57). The intervention group was treated with 20 ml of local epinephrine 0.02% on papilla immediately after ERCP, and the controls with similar volume of normal saline. Demographic factors, procedure-related factors (duration of procedure, volume of contrast, times of cannulation, precut sphinctrotomy, billiary balloon dilatation, asinarization, opacification, and number of pancreatic duct cannulations), as well as amylase, lipase, and hemoglobin levels at baseline and within 24 hour after the procedure were compared between the groups. Besides, the patients were assessed in terms of pancreatitis, bleeding, and perforation incidence within 12 and 24 hours after ERCP.
Findings: The two assessed groups were similar in terms of demographic and procedural-related factors (P > 0.050). Pancreatitis occurred in 1 patient (1.5%) in intervention and 6 ones (10.5%) in control group (P = 0.036). The two groups were not statistically different in terms of amylase and lipase at baseline and after ERCP. Bleeding occurred only a case (1.75%) in the control group and no one experienced perforation.
Conclusion: Based on the findings of the current study, local epinephrine spray can remarkably lead to decreased pancreatitis incidence as compared to the control group; however, it cannot significantly affect the pancreatic enzymes level and pancreatitis severity.

Keywords

References

Dumonceau JM, Andriulli A, Deviere J, Mariani A, Rigaux J, Baron TH, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: Prophylaxis of post-ERCP pancreatitis. Endoscopy 2010; 42(6): 503-15.
Hormati A, Alemi F, Mohammadbeigi A, Sarkeshikian SS, Saeidi M. Prevalence of endoscopic retrograde cholangiopancreatography complications and amylase sensitivity for predicting pancreatitis in ERCP patients. Gastroenterol Nurs 2020; 43(5): 350-4.
Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology 1976; 70(3): 314-20.
Shavakhi A, Khodadustan M, Tamizifar B. The effect of prophylactic peripapillary administration of methylprednisolone in reducing the risk and severity of postendoscopic retrograde cholangiopancreatography pancreatitis: A double blind clinical trial. J Res Med Sci 2015; 20(9): 850-4.
Matsushita M, Takakuwa H, Shimeno N, Uchida K, Nishio A, Okazaki K. Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol 2009; 44(1): 71-5.
Ohashi A, Tamada K, Tomiyama T, Wada S, Higashizawa T, Gotoh Y, et al. Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty. J Gastroenterol Hepatol 2001; 16(5): 568-71.
Vadala di Prampero SF, Faleschini G, Panic N, Bulajic M. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis and systematic review. Eur J Gastroenterol Hepatol 2016; 28(12): 1415-24.
Kubiliun NM, Adams MA, Akshintala VS, Conte ML, Cote GA, Cotton PB, et al. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review. Clin Gastroenterol Hepatol 2015; 13(7): 1231-9.
Alavi NP, Hajiani E, Hashemi J, Masjedizadeh AR, Shayesteh AA, Sebghatollahi V. Evaluation of N-acetyl cysteine for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective double blind randomized pilot study. Middle East J Dig Dis 2013; 5(1): 17-21.
Xu LH, Qian JB, Gu LG, Qiu JW, Ge ZM, Lu F, et al. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla. J Gastroenterol Hepatol 2011; 26(7): 1139-44.
Akshintala VS, Hutfless SM, Colantuoni E, Kim KJ, Khashab MA, Li T, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther 2013; 38(11-12): 1325-37.
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37(3): 383-93.
Hatami B, Kashfi SMH, Abbasinazari M, Nazemalhosseini ME, Pourhoseingholi MA, Zali MR, et al. Epinephrine in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A preliminary study. Case Rep Gastroenterol 2018; 12(1): 125-36.
Dumonceau JM, Rigaux J, Kahaleh M, Gomez CM, Vandermeeren A, Deviere J. Prophylaxis of post-ERCP pancreatitis: A practice survey. Gastrointest Endosc 2010; 71(6): 934-9, 939.
Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V, Ben-Menachem T, et al. Complications of ERCP. Gastrointest Endosc 2012; 75(3): 467-73.
Wang AY, Strand DS, Shami VM. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: medications and techniques. Clin Gastroenterol Hepatol 2016; 14(11): 1521-32.
Nakaji K, Suzumura S, Nakae Y, Kojima K, Kumamoto M, Kozu T. Effects in the control of edema of the papilla of Vater by epinephrine saline irrigation after endoscopic retrograde cholangiopancreatography in an endoscopy center in Japan, 2003 to 2007: exploratory retrospective analysis to evaluate the characteristics of eligible patients with a focus on serum amylase levels. Intern Med 2009; 48(12): 945-52.
Plavsic I, Zitinic I, Mikolasevic I, Poropat G, Hauser G. Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis: Two distinct clinical and immunological entities? World J Gastrointest Endosc 2018; 10(10): 259-66.
Gromski MA, Fogel EL. End of the road for epinephrine spraying of the papilla to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis? Clin Gastroenterol Hepatol 2019; 17(8): 1446-7.
Luo H, Wang X, Zhang R, Liang S, Kang X, Zhang X, et al. rectal indomethacin and spraying of duodenal papilla with epinephrine increases risk of pancreatitis following endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2019; 17(8): 1597-606.
Kamal A, Akshintala VS, Talukdar R, Goenka MK, Kochhar R, Lakhtakia S, et al. A randomized trial of topical epinephrine and rectal indomethacin for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Am J Gastroenterol 2019; 114(2): 339-47.
Hayakawa T, Naruse S, Kitagawa M. Preventative measures of occasional endoscopic retrograde cholangiopancreatography (ERCP)-related conditions: especially post-ERCP acute pancreatitis. Suizo (Journal of the Japan Pancreas Society) 1999; 14: 455-62. [In Japanese].
Matsushita M, Takakuwa H, Shimeno N, Uchida K, Nishio A, Okazaki K. Prophylactic injection of hypertonic saline-epinephrine oral to the papilla for prevention of postsphincterotomy bleeding. J Clin Gastroenterol 2010; 44(8): e167-e170.
Journal of Isfahan Medical School
Volume 39, Issue 621
2021
Pages 254-261

Files

History

  • Receive Date: 01 April 2022
  • Accept Date: 01 April 2022

Share

How to cite

Statistics